vimarsana.com

Latest Breaking News On - News ratings for agios pharmaceuticals daily - Page 1 : vimarsana.com

Agios Pharmaceuticals (NASDAQ:AGIO) Rating Increased to Hold at StockNews com

StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday. Several other analysts also recently weighed in on AGIO. Royal Bank of Canada reduced their target price on Agios Pharmaceuticals from $43.00 to $42.00 and set an outperform […]

Agios Pharmaceuticals (NASDAQ:AGIO) Hits New 1-Year High at $39 70

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $39.70 and last traded at $38.91, with a volume of 573087 shares changing hands. The stock had previously closed at $31.50. Wall Street Analysts Forecast Growth A number of equities analysts have recently […]

Zacks Research Analysts Boost Earnings Estimates for Agios Pharmaceuticals, Inc (NASDAQ:AGIO)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Equities researchers at Zacks Research increased their Q2 2024 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research note issued to investors on Monday, May 20th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will earn ($1.59) per share for […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.